NDC 11704-251

Pralidoxime Chloride

Pralidoxime Chloride

Pralidoxime Chloride is a Intramuscular Injection in the Human Prescription Drug category. It is labeled and distributed by Meridian Medical Technologies, Inc.. The primary component is Pralidoxime Chloride.

• Product ID: 11704-251_c7e5b5e2-5de7-4b70-89d8-92fc6c0d7c40
• NDC: 11704-251
• Product Type: Human Prescription Drug
• Proprietary Name: Pralidoxime Chloride
• Generic Name: Pralidoxime Chloride
• Dosage Form: Injection
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 1983-04-26
• Marketing Category: NDA / NDA
• Application Number: NDA018986
• Labeler Name: Meridian Medical Technologies, Inc.
• Substance Name: PRALIDOXIME CHLORIDE
• Active Ingredient Strength: 600 mg/2mL
• Pharm Classes: Cholinesterase Reactivator [EPC],Cholinesterase Reactivators [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 11704-251-01

1 SYRINGE, GLASS in 1 POUCH (11704-251-01) > 2 mL in 1 SYRINGE, GLASS

• Marketing Start Date: 1983-04-26
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 11704-251-01 [11704025101]

Pralidoxime Chloride INJECTION

• Marketing Category: NDA
• Application Number: NDA018986
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 1983-04-26

Drug Details

Active Ingredients

Ingredient	Strength
PRALIDOXIME CHLORIDE	600 mg/2mL

OpenFDA Data

• SPL SET ID: a16ac225-bb32-4b27-bb66-9e152cf065eb
• Manufacturer:
  • Meridian Medical Technologies, Inc.
• UNII:
  • 38X7XS076H
• RxNorm Concept Unique ID - RxCUI:
  • 727631
• UPC Code:
  • 0311704251019

Pharmacological Class

• Cholinesterase Reactivator [EPC]
• Cholinesterase Reactivators [MoA]
• Cholinesterase Reactivator [EPC]
• Cholinesterase Reactivators [MoA]

NDC Crossover Matching brand name "Pralidoxime Chloride" or generic name "Pralidoxime Chloride"

NDC	Brand Name	Generic Name
11704-251	Pralidoxime Chloride	Pralidoxime Chloride
60977-141	Protopam Chloride	pralidoxime chloride